RA Capital Management - PHASEBIO PHARMACEUTICALS INC ownership

PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 58 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
RA Capital Management ownership history of PHASEBIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$3,762,000
-49.4%
2,850,0000.0%0.08%
-37.4%
Q4 2021$7,439,000
-16.1%
2,850,0000.0%0.13%
+6.5%
Q3 2021$8,864,000
-16.4%
2,850,0000.0%0.12%
-27.6%
Q2 2021$10,602,000
+7.5%
2,850,0000.0%0.17%
+14.1%
Q1 2021$9,861,0002,850,0000.15%
Other shareholders

There were no reported owners of PHASEBIO PHARMACEUTICALS INC in Q1 2022.

NameSharesValueWeighting ↓
View complete list of PHASEBIO PHARMACEUTICALS INC shareholders